High-density lipoprotein 3 cholesterol and primary open-angle glaucoma: metabolomics and mendelian randomization analyses.
暂无分享,去创建一个
T. Wong | J. Crowston | D. Silver | C. Sabanayagam | Ching-Yu Cheng | T. Aung | Yih-Chung Tham | M. Baskaran | Q. Fan | Sahil Thakur | S. Nusinovici | Hengtong Li | Lei Zhou | T. Wong | T. Wong | Y. Tham | T. Wong
[1] Adriana I. Iglesias,et al. Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries , 2021, Nature Communications.
[2] Tom R. Gaunt,et al. Triglyceride-containing lipoprotein sub-fractions and risk of coronary heart disease and stroke: A prospective analysis in 11,560 adults , 2020, European journal of preventive cardiology.
[3] James R. Staley,et al. A robust and efficient method for Mendelian randomization with hundreds of genetic variants , 2020, Nature Communications.
[4] T. Wong,et al. Singapore Chinese Eye Study: key findings from baseline examination and the rationale, methodology of the 6-year follow-up series , 2019, British Journal of Ophthalmology.
[5] Ira M. Hall,et al. Exome sequencing of Finnish isolates enhances rare-variant association power , 2019, Nature.
[6] Stephen Burgess,et al. A comparison of robust Mendelian randomization methods using summary data , 2019, bioRxiv.
[7] Shiming Wang,et al. Hyperlipidemia, Blood Lipid Level, and the Risk of Glaucoma: A Meta-Analysis. , 2019, Investigative ophthalmology & visual science.
[8] Christine Binquet,et al. Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology Consortia. , 2018, Ophthalmology.
[9] D. Lawlor,et al. Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption , 2018, bioRxiv.
[10] V. Salomaa,et al. Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies , 2018, Alzheimer's & Dementia.
[11] V. Salomaa,et al. Cohort Profile: The National FINRISK Study. , 2018, International journal of epidemiology.
[12] T. Lehtimäki,et al. Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts , 2019, bioRxiv.
[13] N. Vuilleumier,et al. Pharmacological Intervention to Modulate HDL: What Do We Target? , 2018, Front. Pharmacol..
[14] R. Ritch,et al. Glaucoma , 2017, The Lancet.
[15] Fernando Pires Hartwig,et al. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption , 2017, bioRxiv.
[16] T. Wong,et al. Singapore Indian Eye Study‐2: methodology and impact of migration on systemic and eye outcomes , 2017, Clinical & experimental ophthalmology.
[17] S. Thompson,et al. Interpreting findings from Mendelian randomization using the MR-Egger method , 2017, European Journal of Epidemiology.
[18] Karen L. Mohlke,et al. The Metabolic Syndrome in Men study: a resource for studies of metabolic and cardiovascular diseases , 2017, Journal of Lipid Research.
[19] G. Davey Smith,et al. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator , 2016, Genetic epidemiology.
[20] G. Davey Smith,et al. Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies1 , 2016, The American journal of clinical nutrition.
[21] K. Park,et al. Prevalence, Awareness, and Risk Factors of Primary Open-Angle Glaucoma: Korea National Health and Nutrition Examination Survey 2008-2011. , 2016, Ophthalmology.
[22] Mervin Chávez-Castillo,et al. Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics , 2015, Cholesterol.
[23] Tin Aung,et al. The Prevalence and Types of Glaucoma in an Urban Chinese Population: The Singapore Chinese Eye Study. , 2015, JAMA ophthalmology.
[24] K. Rye,et al. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. , 2015, Circulation research.
[25] Juan Zhang,et al. Cholesterol metabolism and homeostasis in the brain , 2015, Protein & Cell.
[26] Pasi Soininen,et al. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. , 2015, Circulation. Cardiovascular genetics.
[27] T. Wong,et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. , 2014, Ophthalmology.
[28] T. Wong,et al. Common variants near ABCA1 and in PMM2 are associated with primary open-angle glaucoma , 2014, Nature Genetics.
[29] Janey L. Wiggs,et al. Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma , 2014, Nature Genetics.
[30] P. Visscher,et al. Calculating statistical power in Mendelian randomization studies. , 2013, International journal of epidemiology.
[31] Jingyuan Deng,et al. Multi-dimensional Co-separation Analysis Reveals Protein–Protein Interactions Defining Plasma Lipoprotein Subspecies* , 2013, Molecular & Cellular Proteomics.
[32] B. Pierce,et al. Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable Estimators , 2013, American journal of epidemiology.
[33] Yoshiro Saito,et al. Plasma and serum from nonfasting men and women differ in their lipidomic profiles. , 2013, Biological & pharmaceutical bulletin.
[34] G. Norata,et al. High-Density Lipoprotein Subfractions - What the Clinicians Need to Know , 2013, Cardiology.
[35] P. Mitchell,et al. Singapore Malay Eye Study: rationale and methodology of 6‐year follow‐up study (SiMES‐2) , 2012, Clinical & experimental ophthalmology.
[36] A. Kontush,et al. Biological activities of HDL subpopulations and their relevance to cardiovascular disease. , 2011, Trends in molecular medicine.
[37] C. Creuzot-Garcher,et al. 24S-hydroxycholesterol and cholesterol-24S-hydroxylase (CYP46A1) in the retina: from cholesterol homeostasis to pathophysiology of glaucoma. , 2011, Chemistry and physics of lipids.
[38] Florian Kronenberg,et al. Differences between Human Plasma and Serum Metabolite Profiles , 2011, PloS one.
[39] G. D. Paolo,et al. Linking lipids to Alzheimer's disease: cholesterol and beyond , 2011, Nature Reviews Neuroscience.
[40] S. Reddy,et al. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms , 2011, Nature Reviews Cardiology.
[41] C. Chien,et al. Comparison of comorbid conditions between open-angle glaucoma patients and a control cohort: a case-control study. , 2010, Ophthalmology.
[42] B. Nan,et al. The relationship between components of metabolic syndrome and open-angle glaucoma. , 2010, Ophthalmology.
[43] P. Mitchell,et al. Methodology of the Singapore Indian Chinese Cohort (SICC) Eye Study: Quantifying ethnic variations in the epidemiology of eye diseases in Asians , 2009, Ophthalmic epidemiology.
[44] Alkes L. Price,et al. Reconstructing Indian Population History , 2009, Nature.
[45] J. Lau,et al. Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes , 2009, Annals of Internal Medicine.
[46] Leopold Schmetterer,et al. Endothelial dysfunction in glaucoma , 2009, Acta ophthalmologica.
[47] Peter Kraft,et al. Curses--winner's and otherwise--in genetic epidemiology. , 2008, Epidemiology.
[48] A. Tall,et al. Cholesterol efflux pathways and other potential mechanisms involved in the athero‐protective effect of high density lipoproteins , 2008, Journal of internal medicine.
[49] R. Collins,et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease , 2008, Nature Genetics.
[50] T. Wong,et al. Rationale and Methodology for a Population-Based Study of Eye Diseases in Malay People: The Singapore Malay Eye Study (SiMES) , 2007, Ophthalmic epidemiology.
[51] D. Cook,et al. Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis. , 2006, Investigative ophthalmology & visual science.
[52] P. Foster,et al. The definition and classification of glaucoma in prevalence surveys , 2002, The British journal of ophthalmology.
[53] Richard R. Ernst,et al. Nuclear Magnetic Resonance Fourier Transform Spectroscopy (Nobel Lecture) , 1992 .
[54] R. Mensink,et al. Determinants of cholesterol efflux capacity in humans. , 2018, Progress in lipid research.
[55] Stefan Sperlich,et al. Generalized Additive Models , 2014 .